AVCR — Avricore Health Share News
0.000.00%
Last trade - 00:00- CA$6.32m
- CA$5.40m
- CA$0.53m
Brief: Avricore Health Provides Update On Status Of Management Cease Trade Order
Brief: Avricore Health Announces Late Filing Of Annual Financial Statements And Management Cease Trade Order
Brief: Avricore Health Signs Letter Of Intent To Partner With FoodRocket
Brief: Vanc Pharmaceuticals will change its name to Avricore Health
Brief: Vanc Pharmaceuticals Enters Into Supply And Distribution Agreement With Affiliate Of Emerald Health Therapeutics
Brief: VANC Pharma Entered Sales Broker Agreement With Pinnacle Pharma
Brief: Vanc Pharmaceuticals receives Health Canada class-III approval for ferrous fumarate products
Brief: VANC Pharmaceuticals announces provincial formulary approvals for Atlantic Canada
Brief: Vanc Pharmaceuticals appoints Sherif Guorgui to board
Brief: Vanc Pharmaceuticals provides corporate update
Brief: Vanc Pharmaceuticals announces non brokered private placement
Brief: Vanc Pharmaceuticals says at annual shareholders' meeting Union Venture Trading to nominate own directors
Brief: Vanc Pharmaceuticals respond to demand letter from Canagen Pharmaceuticals
Brief: Vanc Pharmaceuticals provides marketing update
Brief: Vanc Pharmaceuticals launches new OTC laxative product Sennace
Brief: Vanc Pharmaceuticals announces non brokered private placement
Brief: VANC Pharmaceuticals to acquire HealthTab
Brief: Vanc Pharmaceuticals to acquire HealthTab
Brief: VANC Pharmaceuticals says Health Canada approves Van-Fer tablets and capsules